文献速递神经肿瘤

脑膜瘤起源细胞证据挑战蛛网膜帽细胞学说

Current evidence on the cell of origin of meningiomas disputes the arachnoid cap cell dogma.
PubMed 文献 · Acta Neurochir (Wien) · 2026-05-21

本文为小型综述,重新审视脑膜瘤起源的历史观点,并批判性评估传统蛛网膜来源范式的局限。综合单细胞转录组学、空间测序、发育生物学与转基因动物模型证据,提示脑膜瘤细胞起源更复杂且异质,单一细胞来源不足以解释其临床与生物学多样性;未来分类与治疗策略应超越经典蛛网膜帽细胞模型。

要点

  • 脑膜瘤并非仅起源于蛛网膜帽细胞,起源具有异质性。
  • 成纤维细胞样或区域特异性脑膜祖细胞可能是替代来源。
  • 未来分类与治疗策略应考虑细胞来源和解剖环境的多样性。

核心结论

  • 单一细胞来源不足以解释脑膜瘤的临床与生物学多样性。
  • 脑膜瘤发生可能由更广泛的祖细胞谱系驱动,其特征随解剖位置和胚胎谱系而变化。
  • 有必要重新定义脑膜瘤的发生学,未来分类与治疗策略应反映其细胞来源和解剖环境的固有多样性。

研究设计与样本

  • 本文为小型综述(mini-review),回顾历史观点并批判性评估传统蛛网膜范式的局限性。
  • 综合经典组织学见解与当代分子和蛋白质组学数据,探讨替代假说。

主要发现

  • 单细胞转录组学、空间测序、发育生物学和转基因动物模型的新证据提示脑膜瘤细胞起源更复杂且异质。
  • 多组学与发育数据的综合表明单一细胞来源不足以解释脑膜瘤的临床和生物学多样性。
  • 成纤维细胞样或区域特异性脑膜祖细胞等替代假说受到关注。

临床怎么用

  • 未来脑膜瘤分类与治疗策略设计应考虑其细胞来源和解剖环境的多样性,不再局限于经典蛛网膜帽细胞模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: For over a century, the dominant hypothesis has maintained that meningiomas arise exclusively from arachnoid cap cells. However, emerging evidence from single-cell transcriptomics, spatial sequencing, developmental biology, and transgenic animal models suggests a significantly more complex and heterogeneous cellular origin. METHODS: This mini-review revisits historical perspectives and critically evaluates the limitations of the traditional arachnoid-based paradigm. By synthesizing classical histological insights with contemporary molecular and proteomic data, the study explores alternative hypotheses, particularly those implicating fibroblast-like or regionally distinct meningeal progenitors. RESULTS: The synthesis of multi-omic and developmental data indicates that a singular cellular source is insufficient to account for the clinical and biological diversity of meningiomas. Findings suggest that meningioma ontogeny is likely driven by a broader spectrum of progenitors whose characteristics vary according to anatomical location and embryological lineage. CONCLUSIONS: A redefinition of meningioma ontogeny is necessary. Future classification and therapeutic strategies should reflect the inherent diversity of their cellular sources and anatomical environments, moving beyond the classical arachnoid-cap-cell model.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Pamir MN, Erşen-Danyeli A, Özduman K, et al. Current evidence on the cell of origin of meningiomas disputes the arachnoid cap cell dogma. Acta Neurochir (Wien). 2026. PMID: 42165909. doi:10.1007/s00701-026-06908-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。